These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3414330)

  • 1. The morphological characteristics and ultrastructural aspects of cervical ripening induced by sulprostone.
    Di Lieto A; Catalano D; Campanile M; Negri R; Albano G; Dell'Isola A; Paladini A; Orlandi GR
    Acta Eur Fertil; 1988; 19(1):33-6. PubMed ID: 3414330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphologic and biochemical aspects of prostaglandin-induced cervix ripening].
    Rath W; Adelmann-Grill BC; Schauer A; Kuhn W
    Z Geburtshilfe Perinatol; 1987; 191(1):21-8. PubMed ID: 3554798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
    Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
    Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preoperative cervical dilatation in abortion during the 1st trimester with sulprostone].
    Schulz BO; Gethmann U; Lehmann F
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):185-7. PubMed ID: 6562984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological study of uterine cervix during termination of early pregnancy by mifepristone and prostaglandins].
    Weng L; Jiao L; Tang X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):522-5. PubMed ID: 8556909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abortion induction in the 2d pregnancy trimester. Endocervical PGE2 gel administration, intramuscular sulprostone administration and combined (endocervical PGE2 gel/intramuscular sulprostone) treatment].
    Schmidt W; Rabe D; Hendrik HJ
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):261-4. PubMed ID: 3859450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tonometric and tocographic studies of selective priming of the cervix with sulprostone gel in abortion in the 1st trimester].
    Rath W; Schwab E; Harder D; Kuhn W
    Gynakol Rundsch; 1988; 28(1):15-29. PubMed ID: 3286389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dose-dependent effect of locally administered sulprostone gel on serum luteal and placental hormones in cervix priming in the 1st trimester].
    Rath W; Pitzel L; Hilgers R; Kuhn W
    Zentralbl Gynakol; 1989; 111(10):634-44. PubMed ID: 2750356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative cervix priming in the 1st trimester: initial clinical experiences with a combination of Pluronic F 127 and sulprostone].
    Heine O
    Geburtshilfe Frauenheilkd; 1988 Feb; 48(2):102-5. PubMed ID: 3366345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cervix priming in induced abortion in the 1st trimester using intracervical administration of sulprostone gel].
    Rath W; Meyer D; Harder D; Hilgers R; Kuhn W
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):51-6. PubMed ID: 3845028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules.
    Fruzzetti F; Melis GB; Strigini F; Vettori C; Ricci C; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):704-8. PubMed ID: 3173921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of sulprostone in nulliparous patients in voluntary interruption of pregnancy during the first trimester].
    Cipolla L; Gonfiantini A; Giannetta G
    Minerva Ginecol; 1989 Jul; 41(7):365-9. PubMed ID: 2691925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of sulprostone for cervical dilation in nulliparas during 1st trimester abortions].
    Giannone R; Poli M; Bernardi F; Ferrari E
    Minerva Ginecol; 1988 Sep; 40(9):553-5. PubMed ID: 3222011
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.
    Ranjan V; Hingorani V; Kinra G; Agarwal N; Pande Y
    Contraception; 1982 Feb; 25(2):175-84. PubMed ID: 7075190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dinoprostone priming of the cervix prior to termination of midgestation pregnancy with sulprostone.
    Rietberg CC; Lotgering FK; Huikeshoven FJ
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):157-60. PubMed ID: 7641968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.